ISNTD Q&A interview

By Kamran Rafiq

In this exclusive International Society for Neglected Tropical Diseases (ISNTD) interview, Dr. Durrant talks about the adoption of a new pricing model that will guide KaloBios’ strategy and opera- tions, and explains how this framework will help to define and develop transparent and responsible pricing for products as well as positively address the concerns that drug pricing raises for all stakeholders in healthcare.

Read the full Interview